SOPHiA GENETICS (SOPH) Invested Capital (2020 - 2025)

SOPHiA GENETICS (SOPH) has 4 years of Invested Capital data on file, last reported at $47.7 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital rose 218.22% year-over-year to $47.7 million; the trailing twelve-month figure through Dec 2025 stood at $47.7 million (up 218.22% YoY), and the FY2025 full-year result was $47.7 million, up 218.22% from the prior year.
• Invested Capital climbed to $47.7 million in Q4 2025, from $15.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $47.7 million in Q4 2025 to a low of $15.0 million in Q4 2024.
• A 3-year average of $32.8 million and a median of $35.8 million in 2021 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital soared 983.88% in 2021 and soared 218.22% in 2025, its largest moves.
• Tracing SOPH's Invested Capital over 3 years: stood at $35.8 million in 2021, then slumped by 58.06% to $15.0 million in 2024, then soared by 218.22% to $47.7 million in 2025.
• Business Quant data shows SOPH's Invested Capital at $47.7 million in Q4 2025, $15.0 million in Q4 2024, and $35.8 million in Q4 2021.